| Net sales | 35.12M |
| Cost of sales, excluding available unused capacity costs | 29.84M |
| Available unused capacity costs | |
| Gross profit | 5.28M |
| Application and development costs | 2.2M |
| Selling, general and administrative expenses | 3.48M |
| Operating loss | -405K |
| Interest expense, net, including amortization of financing fees and debt discount | |
| Loss on foreign currency transactions | -1.33M |
| Other (expense) income, net | -486K |
| Gain on liabilities carried at fair value | |
| Loss from operations before income taxes | -2.41M |
| Income tax expense (benefit) | -149K |
| Net loss | -2.26M |
| Basic and diluted loss per share (in Dollars per share) | |
| Weighted average common shares outstanding – basic and diluted (in Shares) | 34.39M |